Aktien Sensor

Alnylam Pharmaceuticals presented advancements in RNAi therapeutics for cardiovascular disease at the European Society of Cardiology 2025 Congress.

Mettler-Toledo International Inc’s stock price remains stable, with no significant changes or developments impacting its market value or financial performance.

Haleon PLC has launched Voltaren Dolo Patch 24h in Switzerland, a product designed for long-lasting pain relief.

BioMarin Pharmaceutical’s stock price has fluctuated within a 52-week range, but a recent price target increase by Guggenheim to $106 suggests growing market confidence in the company’s prospects.

Neurocrine Biosciences will present at the Canaccord Genuity 45th Annual Growth Conference, where its recent stock performance and financial metrics will be discussed.

CSL has received approval from Health Canada for its treatment Andembry, which is intended to address hereditary angioedema.

Sanofi has navigated market volatility with a steady hand, thanks to its diversified portfolio, commitment to innovation, and recent breakthroughs in treatments for oncology and cardiovascular diseases.

Argenx SE’s stock price has surged 31% in the past month, driven by the company’s strong quarterly performance, despite regulatory warnings and a securities investigation.

WuXi AppTec’s stock price has been relatively stable compared to its peers, despite the broader market trend of significant gains in the healthcare sector.

Neurocrine Biosciences is set to present at the Canaccord Genuity Conference, but its flagging stock price and valuation metrics raise concerns about the company’s financial performance.